Patents Assigned to Board of Trustees of the University of Illinois
-
Publication number: 20210308064Abstract: Provided herein are stimulus-responsive polymer microgelator particles that can activate fibrin fiber formation from their surfaces by actively ejecting thrombin to form an interconnected fibrin network with an increased elastic modulus and desirable microstructure. The use of the microgelators enables the decoupling of gelation rate and gel rigidity.Type: ApplicationFiled: April 2, 2021Publication date: October 7, 2021Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Hyunjoon KONG, Yu-Tong HONG, Yongbeom SEO
-
Patent number: 11139851Abstract: An apparatus includes parallel delay lines, each exhibiting a delay; a first set of switches for each port of a first set of ports, each of which is to selectively couple a port of the first set of ports to first ends of the delay lines; a second set of switches for each port of a second set of ports, each of which to selectively couple a port of the second set of ports to second ends of the delay lines. A signal source generates a series of clock signals that are sequentially time delayed between the first set of switches and the second set of switches, where an input signal at one of the first or second sets of ports travels back and forth across the first and second sets of delay lines according to activation of the first set and second set of switches until being output.Type: GrantFiled: October 27, 2020Date of Patent: October 5, 2021Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Songbin Gong, Ruochen Lu, John Andrew Krol, Liuqing Gao
-
Patent number: 11140086Abstract: In various aspects, a system that comprises detecting a congestion event in a network that transmits a first group of data packets and a second group of data packets, wherein the detecting the congestion event comprises detecting the congestion event has initiated in response to a data packet throughput value of the network having been determined to have decreased below a threshold value; in response to the detecting of the congestion event, determine a transmission rate of the second group of data packets based on a transmission priority of the second group of data packets; determining a data packet dropping rate for the second group of data packets based on the transmission rate of the second group of data packets and a size of the first group of data packets and transmitting the second group of data packets utilizing the transmission rate and the data packet dropping rate.Type: GrantFiled: August 15, 2019Date of Patent: October 5, 2021Assignees: AT&T INTELLECTUAL PROPERTY I, L.P., THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Emir Halepovic, Vijay Gopalakrishnan, Muhammad Usama Chaudhry, Shanyu Zhou, Balajee Vamanan, Hulya Seferoglu
-
Patent number: 11136693Abstract: A fiber-based device having a reconfigurable geometry comprises an array of hair-like fibers spaced apart on a substrate, where each hair-like fiber comprises a free end extending away from the substrate and a secured end attached to the substrate. The array has a first bundled configuration where the free ends of the hair-like fibers are drawn together into a bundle having a first cross-sectional shape, and a second bundled configuration where the free ends of the hair-like fibers are drawn together into a bundle having a second cross-sectional shape. The array is reconfigurable from the first bundled configuration to the second bundled configuration by exposure to a liquid and then removal of the liquid at a predetermined rate.Type: GrantFiled: September 21, 2018Date of Patent: October 5, 2021Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Sameh H. Tawfick, Dongwoo Shin
-
Patent number: 11139899Abstract: Aspects of the subject disclosure may include, for example, receiving, by a receiver through a medium from a transmitter, signals over an acoustic channel, where the receiving over the acoustic channel utilizes a high center frequency and provides for a high data rate, and where the medium is a fluid or a semi-solid medium. The device can receive power from the transmitter over the acoustic channel. Other embodiments are disclosed.Type: GrantFiled: May 26, 2016Date of Patent: October 5, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: Michael L. Oelze, Thomas Riedl, Andrew Singer
-
Patent number: 11132512Abstract: Embodiments of the invention describe a computer-implemented method that includes receiving a query that includes a query sequence having query characters grouped into query words. A segment of program code is retrieved from a database for evaluation. The program code includes a program code sequence including program code characters grouped into program code words. The query sequence, the query word, the program code sequence, and the program code word are each converted to sequence and word representations. Query sequence-level features, query word-level features, program code sequence-level features, and program code word-level features are extracted from the sequence and word representation. Similarity between the query and the segment of program code is determined by applying a similarity metric technique to the query sequence-level features, the query word-level features, the program code sequence-level features, and the program code word-level features.Type: GrantFiled: November 8, 2019Date of Patent: September 28, 2021Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, The Board of Trustees of the University of IllinoisInventors: Lingfei Wu, Jinjun Xiong, Julia Constanze Hockenmaier, Rajarshi Haldar
-
Patent number: 11129830Abstract: Compositions and methods for the induction of cancer cell death. The compositions and methods of using them include use of compositions in therapy for the treatment of cancer and for the selective induction of apoptosis in cancer cells. The drug combinations described herein can be synergistic and can have lower neurotoxicity effects than the same amounts of other compounds and combinations of compounds and can be effective when a particular cancer has become resistant to previously administered therapies.Type: GrantFiled: June 10, 2019Date of Patent: September 28, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: Paul J. Hergenrother, Jessie Peh
-
Patent number: 11131738Abstract: A method and system provides an acquisition scheme for generating magnetic resonance elastography displacement data with whole-sample coverage, high spatial resolution, and adequate SNR in a short scan time. The method and system can acquire in-plane and through-plane k-space shots over a volume of a sample divided into a plurality of slabs that each include a plurality of non-adjacent slices to obtain three dimensional multiband, multishot data, can apply multiband radio frequency refocusing pulses to the sample, can acquire navigators before readout, and can correct for non-linear motion errors.Type: GrantFiled: September 27, 2019Date of Patent: September 28, 2021Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Curtis L. Johnson, Bradley P. Sutton, Joseph L. Holtrop
-
Publication number: 20210290616Abstract: The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods of use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.Type: ApplicationFiled: December 22, 2020Publication date: September 23, 2021Applicants: The Board of Trustees of the University of Illinois, Vanquish Oncology, Inc., The Johns Hopkins UniversityInventors: Paul J. Hergenrother, Rachel C. BOTHAM, Timothy M. FAN, Mark J. GILBERT, Michael K. HANDLEY, Avadhut JOSHI, Gregory J. RIGGINS, Theodore M. TARASOW
-
Patent number: 11124605Abstract: The invention provides antimicrobial polypeptides (AMPs) with high radial amphiphilicity. Unlike typical AMPs characterized by facial amphiphilicity or biomimetic antimicrobial polymers with randomly distributed charged and hydrophobic groups, these new AMPs are homo-polypeptides with radially amphiphilic structure. They adopt a stable ?-helical conformation with a hydrophobic helical core and a charged exterior shell, formed by flexible hydrophobic side chains with terminal charge group. The radially amphiphilic polypeptides offer several advantages over conventional AMPs with regard to stability against protease and simplicity of design. They also exhibit high antibacterial activity against both Gram-negative and Gram-positive bacteria and low hemolytic activity. The AMPs thus provide a general platform for treating drug-resistant bacterial infections.Type: GrantFiled: June 27, 2016Date of Patent: September 21, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: Jianjun Cheng, Menghua Xiong, Ziyuan Song
-
Patent number: 11124791Abstract: Methods for screening of affinity reagents for many target proteins of interest simultaneously. Arrayed targets (e.g., peptide, protein, RNA, cell, etc.) are used in affinity selection experiments to reduce the amount of target needed and to improve the throughput of discovering recombinant affinity reagents to a large collection of targets.Type: GrantFiled: September 13, 2016Date of Patent: September 21, 2021Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Joshua Labaer, Kevin Gorman, Brian Kay, Jie Wang, Ji Qiu
-
Patent number: 11117091Abstract: Method and apparatus for separating a target substance from a fluid or mixture. Capsules having a coating and stripping solvents encapsulated in the capsules are provided. The coating is permeable to the target substance. The capsules having a coating and stripping solvents encapsulated in the capsules are exposed to the fluid or mixture. The target substance migrates through the coating and is taken up by the stripping solvents. The target substance is separated from the fluid or mixture by driving off the target substance from the capsules.Type: GrantFiled: July 16, 2018Date of Patent: September 14, 2021Assignees: Lawrence Livermore National Security, LLC, The Board of Trustees of the University of IllinoisInventors: Roger D. Aines, Christopher M. Spadaccini, Joshuah K. Stolaroff, William L. Bourcier, Jennifer A. Lewis, Eric B. Duoss, John J. Vericella
-
Patent number: 11121190Abstract: Provided is an optoelectronic device comprising an optoelectronic element and circuitry connected to the optoelectronic element, wherein the optoelectronic element comprises plural quantum dots or plural nanorods, and wherein the circuitry is configured to be capable of switching the optoelectronic element between a configuration in which the circuitry provides an effective forward bias voltage that causes the optoelectronic element to emit light and a configuration in which the circuitry provides an effective reverse bias voltage that causes the optoelectronic element to be capable of generating a photocurrent when light to which the optoelectronic element is sensitive strikes the optoelectronic element.Type: GrantFiled: March 23, 2017Date of Patent: September 14, 2021Assignees: Dow Global Technologies LLC, Rohm and Haas Company, The Board of Trustees of the University of Illinois, Rohm and Haas Electronic Materials LLCInventors: Peter Trefonas, III, Kishori Deshpande, Trevor Ewers, Edward Greer, Jaebum Joo, Bong Hoon Kim, Nuri Oh, Jong Keun Park, Moonsub Shim, Jieqian Zhang
-
Patent number: 11118965Abstract: The invention provides systems and methods for tissue-mounted electronics and photonics. Devices of some embodiments of the invention implement high performance, and optionally flexible, device components having miniaturized formats in device architectures that minimize adverse physical effects to tissue and/or reduce interfacial stresses when mounted on tissue surfaces. In some embodiments, the invention provides complementary tissue mounting strategies providing for mechanically robust and/or long term integration of the present devices, for example, via mounting on tissue surfaces that are not subject to rapid growth or exfoliation processes such as the fingernail, toenail, tooth or earlobe. Devices of the invention are versatile and support a broad range of applications for sensing, actuating and communication including applications for near field communication, for example, for password authentication, electronic transactions and biometric sensing.Type: GrantFiled: April 29, 2020Date of Patent: September 14, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: John A. Rogers, Anthony R. Banks, Jeonghyun Kim, Gregory Brown
-
Patent number: 11117920Abstract: Provided are certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained anti-fungal activity. Certain of the derivatives are C16 urea derivatives of AmB. Certain of the derivatives are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB. Certain of the derivatives include C3? or C4? modifications of the mycosamine appendage of AmB. Also provided are methods of making AmB derivatives of the invention, pharmaceutical compositions comprising AmB derivatives of the invention, and methods of use of AmB derivatives of the invention.Type: GrantFiled: June 17, 2019Date of Patent: September 14, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: Martin D. Burke, Stephen Davis, Brice E. Uno, Justin Struble, Ian Dailey, Kaitlyn C. Gray, David M. Knapp, Pulin Wang, Nagarjuna Palyam
-
Publication number: 20210276951Abstract: A set of small molecules ER? biomodulators that kill therapy-resistant ER? positive breast, ovarian, and endometrial cancer cells. These small molecules have increased therapeutic potential because of an increased ability to kill therapy-resistant breast cancer cells compared to BHPI and other conventional therapies (endocrine therapies, tamoxifen and fulvestrant/ICI). The new compounds do not only inhibit proliferation of the cancer cells but actually kills them, which prevents reactivation of tumors years later.Type: ApplicationFiled: July 1, 2019Publication date: September 9, 2021Applicant: The Board of Trustees of the University of IllinoisInventors: David J. SHAPIRO, Paul J. HERGENROTHER, Matthew W. BOUDREAU
-
Patent number: 11111378Abstract: The present disclosure provides a composition of matter comprising purified cyclic poly(phthalaldehyde) (cPPA) and a plasticizer. The composition enables thermal processing and molding in bulk quantities, and is designed to degrade when contacted by an acid or exposed to a high enough temperature. Photodegradable cPPA containing a photooxidant is disclosed. Methods of making and recycling the composition of matter are also provided.Type: GrantFiled: April 12, 2019Date of Patent: September 7, 2021Assignee: The Board of Trustees of the University of IllinoisInventors: Jeffrey S. Moore, Scott R. White, Nancy R. Sottos, Adam M. Feinberg, Christopher L. Plantz, Hector Lopez-Hernandez, Evan M. Lloyd
-
Patent number: 11112869Abstract: Provided are actuation devices, virtual reality devices formed from the actuation devices, and related virtual reality methods. The devices may comprise a plurality of spatially distributed actuators, each actuator configured for interacting with a biological skin surface; a wireless controller configured to receive operative command signals to control each of the actuators; and a wireless power system to power the actuators. Also provided are unique layouts of multiple interconnected devices to achieve large area coverage.Type: GrantFiled: January 26, 2018Date of Patent: September 7, 2021Assignees: NORTHWESTERN UNIVERSITY, THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: John A. Rogers, Shuai Xu, In Hwa Jung, Ha Uk Chung, Xinge Yu, Yu Yang, Jungyup Lee, Rujie Sun
-
Patent number: 11112145Abstract: Artificial dense granules composed of a sterically stabilized liposome shell encapsulating a polyphosphate nanoparticle core are provided as are methods for their production and use in the treatment of a severe hemorrhagic event.Type: GrantFiled: September 24, 2015Date of Patent: September 7, 2021Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOISInventors: Ying Liu, Alexander Donovan
-
Patent number: 11097014Abstract: A nanoparticle delivery system designed for sustained delivery of microRNA-150 (miR-150) to FLT3-overexpressing acute myeloid leukemia (AML) cells, the delivery system comprising poly(amidoamine) (PAMAM) dendrimers complexed with miR-150, wherein at least one dendrimer is surface-functionalized with a ligand specific for FLT3 receptor, and methods for treating AML characterized by FLT3-overexpression are provided.Type: GrantFiled: June 14, 2017Date of Patent: August 24, 2021Assignees: University of Cincinnati, Board of Trustees of the University of Illinois, University of ChicagoInventors: Jianjun Chen, Seungpyo Hong, Xi Jiang, Zejuan Li